Pharmacologic evaluation of CI-775, a cardioselective beta adrenergic antagonist.
D000319:Adrenergic beta-Antagonists; D000779:Anesthetics, Local; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004357:Drug Synergism; D005260:Female; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects*; D066298:In Vitro Techniques; D007329:Insulin Antagonists; D007545:Isoproterenol / Q000037:antagonists & inhibitors; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects*; D011217:Practolol / Q000494:pharmacology; D011412:Propanolamines / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D014132:Trachea / Q000187:drug effects; D014882:Water-Electrolyte Balance / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000779:Anesthetics, Local; D007329:Insulin Antagonists; D011412:Propanolamines; C021148:bevantolol; D011433:Propranolol; D007545:Isoproterenol; D011217:Practolol